Nordic Bioscience’s ProteinFingerPrint Technology™ is backed by more than 30 years of research and used by world-leading pharmaceutical companies. Our extracellular matrix-based approach quantifies disease activity with precision unmatched by omics providers, offering mechanistic and pharmacodynamic insights into tissue remodeling, a process crucial to understand when evaluating the effect of a therapeutic intervention.
Biomarkers for different diseases
Unlock the potential of our biomarker technology to uncover key insights into tissue health. This is crucial because many diseases disrupt the balance between tissue formation and breakdown, leading to issues like fibrosis or tissue loss.
